Global Prescription Weight Loss Pills Market Growth 2026-2032
The global Prescription Weight Loss Pills market size is predicted to grow from US$ 1696 million in 2025 to US$ 3431 million in 2032; it is expected to grow at a CAGR of 10.8% from 2026 to 2032.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
Rising conditions such as obesity, cardiovascular diseases, diabetes, and hypertension are increasing the revenue share of the global weight loss drugs market. Moreover, these drugs are used to maintain a healthy body weight amid growing adoption of a healthy lifestyle, thereby driving the expansion of the market revenue.
LP Information, Inc. (LPI) ' newest research report, the ?Prescription Weight Loss Pills Industry Forecast? looks at past sales and reviews total world Prescription Weight Loss Pills sales in 2025, providing a comprehensive analysis by region and market sector of projected Prescription Weight Loss Pills sales for 2026 through 2032. With Prescription Weight Loss Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Weight Loss Pills industry.
This Insight Report provides a comprehensive analysis of the global Prescription Weight Loss Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Weight Loss Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prescription Weight Loss Pills market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Weight Loss Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Weight Loss Pills.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Weight Loss Pills market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
Rising conditions such as obesity, cardiovascular diseases, diabetes, and hypertension are increasing the revenue share of the global weight loss drugs market. Moreover, these drugs are used to maintain a healthy body weight amid growing adoption of a healthy lifestyle, thereby driving the expansion of the market revenue.
LP Information, Inc. (LPI) ' newest research report, the ?Prescription Weight Loss Pills Industry Forecast? looks at past sales and reviews total world Prescription Weight Loss Pills sales in 2025, providing a comprehensive analysis by region and market sector of projected Prescription Weight Loss Pills sales for 2026 through 2032. With Prescription Weight Loss Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prescription Weight Loss Pills industry.
This Insight Report provides a comprehensive analysis of the global Prescription Weight Loss Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prescription Weight Loss Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prescription Weight Loss Pills market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prescription Weight Loss Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prescription Weight Loss Pills.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Weight Loss Pills market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral Tablets
- Oral Capsules
- Injections
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Currax Pharmaceuticals (Contrave)
- VIVUS (Qsymia)
- Novo Nordisk A/S
- Rhythm Pharmaceuticals (Imcivree)
- Eli Lilly and Company (TRICARE)
- CHEPLAPHARM (Xenical)
- Pfizer
- Teva Pharmaceutical (Actavis)
- Haleon Group (alli)
- Sanofi (Adlyxin)
- AstraZeneca (BYDUREON BCise)
- What is the 10-year outlook for the global Prescription Weight Loss Pills market?
- What factors are driving Prescription Weight Loss Pills market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Prescription Weight Loss Pills market opportunities vary by end market size?
- How does Prescription Weight Loss Pills break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prescription Weight Loss Pills Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Prescription Weight Loss Pills by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Prescription Weight Loss Pills by Country/Region, 2021, 2025 & 2032
2.2 Prescription Weight Loss Pills Segment by Type
2.2.1 Oral Tablets
2.2.2 Oral Capsules
2.2.3 Injections
2.2.4 Prescription Weight Loss Pills Sales by Type
2.2.4.1 Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
2.2.4.2 Global Prescription Weight Loss Pills Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Prescription Weight Loss Pills Sale Price by Type (2021-2026)
2.3 Prescription Weight Loss Pills Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Prescription Weight Loss Pills Sales by Application
2.3.3.1 Global Prescription Weight Loss Pills Sale Market Share by Application (2021-2026)
2.3.3.2 Global Prescription Weight Loss Pills Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Prescription Weight Loss Pills Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Prescription Weight Loss Pills Breakdown Data by Company
3.1.1 Global Prescription Weight Loss Pills Annual Sales by Company (2021-2026)
3.1.2 Global Prescription Weight Loss Pills Sales Market Share by Company (2021-2026)
3.2 Global Prescription Weight Loss Pills Annual Revenue by Company (2021-2026)
3.2.1 Global Prescription Weight Loss Pills Revenue by Company (2021-2026)
3.2.2 Global Prescription Weight Loss Pills Revenue Market Share by Company (2021-2026)
3.3 Global Prescription Weight Loss Pills Sale Price by Company
3.4 Key Manufacturers Prescription Weight Loss Pills Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Weight Loss Pills Product Location Distribution
3.4.2 Players Prescription Weight Loss Pills Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRESCRIPTION WEIGHT LOSS PILLS BY GEOGRAPHIC REGION
4.1 World Historic Prescription Weight Loss Pills Market Size by Geographic Region (2021-2026)
4.1.1 Global Prescription Weight Loss Pills Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Prescription Weight Loss Pills Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Prescription Weight Loss Pills Market Size by Country/Region (2021-2026)
4.2.1 Global Prescription Weight Loss Pills Annual Sales by Country/Region (2021-2026)
4.2.2 Global Prescription Weight Loss Pills Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prescription Weight Loss Pills Sales Growth
4.4 APAC Prescription Weight Loss Pills Sales Growth
4.5 Europe Prescription Weight Loss Pills Sales Growth
4.6 Middle East & Africa Prescription Weight Loss Pills Sales Growth
5 AMERICAS
5.1 Americas Prescription Weight Loss Pills Sales by Country
5.1.1 Americas Prescription Weight Loss Pills Sales by Country (2021-2026)
5.1.2 Americas Prescription Weight Loss Pills Revenue by Country (2021-2026)
5.2 Americas Prescription Weight Loss Pills Sales by Type (2021-2026)
5.3 Americas Prescription Weight Loss Pills Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Weight Loss Pills Sales by Region
6.1.1 APAC Prescription Weight Loss Pills Sales by Region (2021-2026)
6.1.2 APAC Prescription Weight Loss Pills Revenue by Region (2021-2026)
6.2 APAC Prescription Weight Loss Pills Sales by Type (2021-2026)
6.3 APAC Prescription Weight Loss Pills Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prescription Weight Loss Pills by Country
7.1.1 Europe Prescription Weight Loss Pills Sales by Country (2021-2026)
7.1.2 Europe Prescription Weight Loss Pills Revenue by Country (2021-2026)
7.2 Europe Prescription Weight Loss Pills Sales by Type (2021-2026)
7.3 Europe Prescription Weight Loss Pills Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prescription Weight Loss Pills by Country
8.1.1 Middle East & Africa Prescription Weight Loss Pills Sales by Country (2021-2026)
8.1.2 Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2021-2026)
8.2 Middle East & Africa Prescription Weight Loss Pills Sales by Type (2021-2026)
8.3 Middle East & Africa Prescription Weight Loss Pills Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills
10.3 Manufacturing Process Analysis of Prescription Weight Loss Pills
10.4 Industry Chain Structure of Prescription Weight Loss Pills
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Weight Loss Pills Distributors
11.3 Prescription Weight Loss Pills Customer
12 WORLD FORECAST REVIEW FOR PRESCRIPTION WEIGHT LOSS PILLS BY GEOGRAPHIC REGION
12.1 Global Prescription Weight Loss Pills Market Size Forecast by Region
12.1.1 Global Prescription Weight Loss Pills Forecast by Region (2027-2032)
12.1.2 Global Prescription Weight Loss Pills Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Prescription Weight Loss Pills Forecast by Type (2027-2032)
12.7 Global Prescription Weight Loss Pills Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Currax Pharmaceuticals (Contrave)
13.1.1 Currax Pharmaceuticals (Contrave) Company Information
13.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolios and Specifications
13.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Currax Pharmaceuticals (Contrave) Main Business Overview
13.1.5 Currax Pharmaceuticals (Contrave) Latest Developments
13.2 VIVUS (Qsymia)
13.2.1 VIVUS (Qsymia) Company Information
13.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolios and Specifications
13.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 VIVUS (Qsymia) Main Business Overview
13.2.5 VIVUS (Qsymia) Latest Developments
13.3 Novo Nordisk A/S
13.3.1 Novo Nordisk A/S Company Information
13.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolios and Specifications
13.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novo Nordisk A/S Main Business Overview
13.3.5 Novo Nordisk A/S Latest Developments
13.4 Rhythm Pharmaceuticals (Imcivree)
13.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information
13.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolios and Specifications
13.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Rhythm Pharmaceuticals (Imcivree) Main Business Overview
13.4.5 Rhythm Pharmaceuticals (Imcivree) Latest Developments
13.5 Eli Lilly and Company (TRICARE)
13.5.1 Eli Lilly and Company (TRICARE) Company Information
13.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolios and Specifications
13.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Company (TRICARE) Main Business Overview
13.5.5 Eli Lilly and Company (TRICARE) Latest Developments
13.6 CHEPLAPHARM (Xenical)
13.6.1 CHEPLAPHARM (Xenical) Company Information
13.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolios and Specifications
13.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CHEPLAPHARM (Xenical) Main Business Overview
13.6.5 CHEPLAPHARM (Xenical) Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Prescription Weight Loss Pills Product Portfolios and Specifications
13.7.3 Pfizer Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Teva Pharmaceutical (Actavis)
13.8.1 Teva Pharmaceutical (Actavis) Company Information
13.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Teva Pharmaceutical (Actavis) Main Business Overview
13.8.5 Teva Pharmaceutical (Actavis) Latest Developments
13.9 Haleon Group (alli)
13.9.1 Haleon Group (alli) Company Information
13.9.2 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolios and Specifications
13.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Haleon Group (alli) Main Business Overview
13.9.5 Haleon Group (alli) Latest Developments
13.10 Sanofi (Adlyxin)
13.10.1 Sanofi (Adlyxin) Company Information
13.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolios and Specifications
13.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi (Adlyxin) Main Business Overview
13.10.5 Sanofi (Adlyxin) Latest Developments
13.11 AstraZeneca (BYDUREON BCise)
13.11.1 AstraZeneca (BYDUREON BCise) Company Information
13.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolios and Specifications
13.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 AstraZeneca (BYDUREON BCise) Main Business Overview
13.11.5 AstraZeneca (BYDUREON BCise) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prescription Weight Loss Pills Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Prescription Weight Loss Pills by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Prescription Weight Loss Pills by Country/Region, 2021, 2025 & 2032
2.2 Prescription Weight Loss Pills Segment by Type
2.2.1 Oral Tablets
2.2.2 Oral Capsules
2.2.3 Injections
2.2.4 Prescription Weight Loss Pills Sales by Type
2.2.4.1 Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
2.2.4.2 Global Prescription Weight Loss Pills Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Prescription Weight Loss Pills Sale Price by Type (2021-2026)
2.3 Prescription Weight Loss Pills Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Prescription Weight Loss Pills Sales by Application
2.3.3.1 Global Prescription Weight Loss Pills Sale Market Share by Application (2021-2026)
2.3.3.2 Global Prescription Weight Loss Pills Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Prescription Weight Loss Pills Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Prescription Weight Loss Pills Breakdown Data by Company
3.1.1 Global Prescription Weight Loss Pills Annual Sales by Company (2021-2026)
3.1.2 Global Prescription Weight Loss Pills Sales Market Share by Company (2021-2026)
3.2 Global Prescription Weight Loss Pills Annual Revenue by Company (2021-2026)
3.2.1 Global Prescription Weight Loss Pills Revenue by Company (2021-2026)
3.2.2 Global Prescription Weight Loss Pills Revenue Market Share by Company (2021-2026)
3.3 Global Prescription Weight Loss Pills Sale Price by Company
3.4 Key Manufacturers Prescription Weight Loss Pills Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Weight Loss Pills Product Location Distribution
3.4.2 Players Prescription Weight Loss Pills Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRESCRIPTION WEIGHT LOSS PILLS BY GEOGRAPHIC REGION
4.1 World Historic Prescription Weight Loss Pills Market Size by Geographic Region (2021-2026)
4.1.1 Global Prescription Weight Loss Pills Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Prescription Weight Loss Pills Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Prescription Weight Loss Pills Market Size by Country/Region (2021-2026)
4.2.1 Global Prescription Weight Loss Pills Annual Sales by Country/Region (2021-2026)
4.2.2 Global Prescription Weight Loss Pills Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prescription Weight Loss Pills Sales Growth
4.4 APAC Prescription Weight Loss Pills Sales Growth
4.5 Europe Prescription Weight Loss Pills Sales Growth
4.6 Middle East & Africa Prescription Weight Loss Pills Sales Growth
5 AMERICAS
5.1 Americas Prescription Weight Loss Pills Sales by Country
5.1.1 Americas Prescription Weight Loss Pills Sales by Country (2021-2026)
5.1.2 Americas Prescription Weight Loss Pills Revenue by Country (2021-2026)
5.2 Americas Prescription Weight Loss Pills Sales by Type (2021-2026)
5.3 Americas Prescription Weight Loss Pills Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Weight Loss Pills Sales by Region
6.1.1 APAC Prescription Weight Loss Pills Sales by Region (2021-2026)
6.1.2 APAC Prescription Weight Loss Pills Revenue by Region (2021-2026)
6.2 APAC Prescription Weight Loss Pills Sales by Type (2021-2026)
6.3 APAC Prescription Weight Loss Pills Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prescription Weight Loss Pills by Country
7.1.1 Europe Prescription Weight Loss Pills Sales by Country (2021-2026)
7.1.2 Europe Prescription Weight Loss Pills Revenue by Country (2021-2026)
7.2 Europe Prescription Weight Loss Pills Sales by Type (2021-2026)
7.3 Europe Prescription Weight Loss Pills Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prescription Weight Loss Pills by Country
8.1.1 Middle East & Africa Prescription Weight Loss Pills Sales by Country (2021-2026)
8.1.2 Middle East & Africa Prescription Weight Loss Pills Revenue by Country (2021-2026)
8.2 Middle East & Africa Prescription Weight Loss Pills Sales by Type (2021-2026)
8.3 Middle East & Africa Prescription Weight Loss Pills Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills
10.3 Manufacturing Process Analysis of Prescription Weight Loss Pills
10.4 Industry Chain Structure of Prescription Weight Loss Pills
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Weight Loss Pills Distributors
11.3 Prescription Weight Loss Pills Customer
12 WORLD FORECAST REVIEW FOR PRESCRIPTION WEIGHT LOSS PILLS BY GEOGRAPHIC REGION
12.1 Global Prescription Weight Loss Pills Market Size Forecast by Region
12.1.1 Global Prescription Weight Loss Pills Forecast by Region (2027-2032)
12.1.2 Global Prescription Weight Loss Pills Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Prescription Weight Loss Pills Forecast by Type (2027-2032)
12.7 Global Prescription Weight Loss Pills Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Currax Pharmaceuticals (Contrave)
13.1.1 Currax Pharmaceuticals (Contrave) Company Information
13.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolios and Specifications
13.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Currax Pharmaceuticals (Contrave) Main Business Overview
13.1.5 Currax Pharmaceuticals (Contrave) Latest Developments
13.2 VIVUS (Qsymia)
13.2.1 VIVUS (Qsymia) Company Information
13.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolios and Specifications
13.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 VIVUS (Qsymia) Main Business Overview
13.2.5 VIVUS (Qsymia) Latest Developments
13.3 Novo Nordisk A/S
13.3.1 Novo Nordisk A/S Company Information
13.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolios and Specifications
13.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novo Nordisk A/S Main Business Overview
13.3.5 Novo Nordisk A/S Latest Developments
13.4 Rhythm Pharmaceuticals (Imcivree)
13.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information
13.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolios and Specifications
13.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Rhythm Pharmaceuticals (Imcivree) Main Business Overview
13.4.5 Rhythm Pharmaceuticals (Imcivree) Latest Developments
13.5 Eli Lilly and Company (TRICARE)
13.5.1 Eli Lilly and Company (TRICARE) Company Information
13.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolios and Specifications
13.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Company (TRICARE) Main Business Overview
13.5.5 Eli Lilly and Company (TRICARE) Latest Developments
13.6 CHEPLAPHARM (Xenical)
13.6.1 CHEPLAPHARM (Xenical) Company Information
13.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolios and Specifications
13.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 CHEPLAPHARM (Xenical) Main Business Overview
13.6.5 CHEPLAPHARM (Xenical) Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Prescription Weight Loss Pills Product Portfolios and Specifications
13.7.3 Pfizer Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Teva Pharmaceutical (Actavis)
13.8.1 Teva Pharmaceutical (Actavis) Company Information
13.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Teva Pharmaceutical (Actavis) Main Business Overview
13.8.5 Teva Pharmaceutical (Actavis) Latest Developments
13.9 Haleon Group (alli)
13.9.1 Haleon Group (alli) Company Information
13.9.2 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolios and Specifications
13.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Haleon Group (alli) Main Business Overview
13.9.5 Haleon Group (alli) Latest Developments
13.10 Sanofi (Adlyxin)
13.10.1 Sanofi (Adlyxin) Company Information
13.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolios and Specifications
13.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi (Adlyxin) Main Business Overview
13.10.5 Sanofi (Adlyxin) Latest Developments
13.11 AstraZeneca (BYDUREON BCise)
13.11.1 AstraZeneca (BYDUREON BCise) Company Information
13.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolios and Specifications
13.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 AstraZeneca (BYDUREON BCise) Main Business Overview
13.11.5 AstraZeneca (BYDUREON BCise) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prescription Weight Loss Pills Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Prescription Weight Loss Pills Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of OralTablets
Table 4. Major Players of Oral Capsules
Table 5. Major Players of Injections
Table 6. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 7. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Table 8. Global Prescription Weight Loss Pills Revenue by Type (2021-2026) & ($ million)
Table 9. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026)
Table 10. Global Prescription Weight Loss Pills Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Prescription Weight Loss Pills Sale by Application (2021-2026) & (K Units)
Table 12. Global Prescription Weight Loss Pills Sale Market Share by Application (2021-2026)
Table 13. Global Prescription Weight Loss Pills Revenue by Application (2021-2026) & ($ million)
Table 14. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2026)
Table 15. Global Prescription Weight Loss Pills Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Prescription Weight Loss Pills Sales by Company (2021-2026) & (K Units)
Table 17. Global Prescription Weight Loss Pills Sales Market Share by Company (2021-2026)
Table 18. Global Prescription Weight Loss Pills Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Prescription Weight Loss Pills Revenue Market Share by Company (2021-2026)
Table 20. Global Prescription Weight Loss Pills Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Prescription Weight Loss Pills Producing Area Distribution and Sales Area
Table 22. Players Prescription Weight Loss Pills Products Offered
Table 23. Prescription Weight Loss Pills Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Prescription Weight Loss Pills Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Prescription Weight Loss Pills Sales Market Share Geographic Region (2021-2026)
Table 28. Global Prescription Weight Loss Pills Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Prescription Weight Loss Pills Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Prescription Weight Loss Pills Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Prescription Weight Loss Pills Sales Market Share by Country/Region (2021-2026)
Table 32. Global Prescription Weight Loss Pills Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Prescription Weight Loss Pills Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 35. Americas Prescription Weight Loss Pills Sales Market Share by Country (2021-2026)
Table 36. Americas Prescription Weight Loss Pills Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 38. Americas Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 39. APAC Prescription Weight Loss Pills Sales by Region (2021-2026) & (K Units)
Table 40. APAC Prescription Weight Loss Pills Sales Market Share by Region (2021-2026)
Table 41. APAC Prescription Weight Loss Pills Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 43. APAC Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 44. Europe Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 45. Europe Prescription Weight Loss Pills Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 47. Europe Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Prescription Weight Loss Pills
Table 53. Key Market Challenges & Risks of Prescription Weight Loss Pills
Table 54. Key Industry Trends of Prescription Weight Loss Pills
Table 55. Prescription Weight Loss Pills Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Prescription Weight Loss Pills Distributors List
Table 58. Prescription Weight Loss Pills Customer List
Table 59. Global Prescription Weight Loss Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Prescription Weight Loss Pills Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Prescription Weight Loss Pills Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Prescription Weight Loss Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Prescription Weight Loss Pills Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Prescription Weight Loss Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Prescription Weight Loss Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Prescription Weight Loss Pills Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Prescription Weight Loss Pills Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Prescription Weight Loss Pills Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Prescription Weight Loss Pills Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Currax Pharmaceuticals (Contrave) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 74. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 75. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Currax Pharmaceuticals (Contrave) Main Business
Table 77. Currax Pharmaceuticals (Contrave) Latest Developments
Table 78. VIVUS (Qsymia) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 79. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 80. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. VIVUS (Qsymia) Main Business
Table 82. VIVUS (Qsymia) Latest Developments
Table 83. Novo Nordisk A/S Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 84. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolios and Specifications
Table 85. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novo Nordisk A/S Main Business
Table 87. Novo Nordisk A/S Latest Developments
Table 88. Rhythm Pharmaceuticals (Imcivree) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 89. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 90. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Rhythm Pharmaceuticals (Imcivree) Main Business
Table 92. Rhythm Pharmaceuticals (Imcivree) Latest Developments
Table 93. Eli Lilly and Company (TRICARE) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 95. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Eli Lilly and Company (TRICARE) Main Business
Table 97. Eli Lilly and Company (TRICARE) Latest Developments
Table 98. CHEPLAPHARM (Xenical) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 99. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 100. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. CHEPLAPHARM (Xenical) Main Business
Table 102. CHEPLAPHARM (Xenical) Latest Developments
Table 103. Pfizer Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Prescription Weight Loss Pills Product Portfolios and Specifications
Table 105. Pfizer Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Teva Pharmaceutical (Actavis) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 110. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Teva Pharmaceutical (Actavis) Main Business
Table 112. Teva Pharmaceutical (Actavis) Latest Developments
Table 113. Haleon Group (alli) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 114. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 115. Haleon Group (alli) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Haleon Group (alli) Main Business
Table 117. Haleon Group (alli) Latest Developments
Table 118. Sanofi (Adlyxin) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 120. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Sanofi (Adlyxin) Main Business
Table 122. Sanofi (Adlyxin) Latest Developments
Table 123. AstraZeneca (BYDUREON BCise) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 124. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 125. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. AstraZeneca (BYDUREON BCise) Main Business
Table 127. AstraZeneca (BYDUREON BCise) Latest Developments
Table 1. Prescription Weight Loss Pills Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Prescription Weight Loss Pills Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of OralTablets
Table 4. Major Players of Oral Capsules
Table 5. Major Players of Injections
Table 6. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 7. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Table 8. Global Prescription Weight Loss Pills Revenue by Type (2021-2026) & ($ million)
Table 9. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026)
Table 10. Global Prescription Weight Loss Pills Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Prescription Weight Loss Pills Sale by Application (2021-2026) & (K Units)
Table 12. Global Prescription Weight Loss Pills Sale Market Share by Application (2021-2026)
Table 13. Global Prescription Weight Loss Pills Revenue by Application (2021-2026) & ($ million)
Table 14. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2026)
Table 15. Global Prescription Weight Loss Pills Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Prescription Weight Loss Pills Sales by Company (2021-2026) & (K Units)
Table 17. Global Prescription Weight Loss Pills Sales Market Share by Company (2021-2026)
Table 18. Global Prescription Weight Loss Pills Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Prescription Weight Loss Pills Revenue Market Share by Company (2021-2026)
Table 20. Global Prescription Weight Loss Pills Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Prescription Weight Loss Pills Producing Area Distribution and Sales Area
Table 22. Players Prescription Weight Loss Pills Products Offered
Table 23. Prescription Weight Loss Pills Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Prescription Weight Loss Pills Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Prescription Weight Loss Pills Sales Market Share Geographic Region (2021-2026)
Table 28. Global Prescription Weight Loss Pills Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Prescription Weight Loss Pills Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Prescription Weight Loss Pills Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Prescription Weight Loss Pills Sales Market Share by Country/Region (2021-2026)
Table 32. Global Prescription Weight Loss Pills Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Prescription Weight Loss Pills Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 35. Americas Prescription Weight Loss Pills Sales Market Share by Country (2021-2026)
Table 36. Americas Prescription Weight Loss Pills Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 38. Americas Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 39. APAC Prescription Weight Loss Pills Sales by Region (2021-2026) & (K Units)
Table 40. APAC Prescription Weight Loss Pills Sales Market Share by Region (2021-2026)
Table 41. APAC Prescription Weight Loss Pills Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 43. APAC Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 44. Europe Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 45. Europe Prescription Weight Loss Pills Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 47. Europe Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Prescription Weight Loss Pills Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Prescription Weight Loss Pills Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Prescription Weight Loss Pills Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Prescription Weight Loss Pills
Table 53. Key Market Challenges & Risks of Prescription Weight Loss Pills
Table 54. Key Industry Trends of Prescription Weight Loss Pills
Table 55. Prescription Weight Loss Pills Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Prescription Weight Loss Pills Distributors List
Table 58. Prescription Weight Loss Pills Customer List
Table 59. Global Prescription Weight Loss Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Prescription Weight Loss Pills Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Prescription Weight Loss Pills Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Prescription Weight Loss Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Prescription Weight Loss Pills Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Prescription Weight Loss Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Prescription Weight Loss Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Prescription Weight Loss Pills Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Prescription Weight Loss Pills Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Prescription Weight Loss Pills Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Prescription Weight Loss Pills Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Currax Pharmaceuticals (Contrave) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 74. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 75. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Currax Pharmaceuticals (Contrave) Main Business
Table 77. Currax Pharmaceuticals (Contrave) Latest Developments
Table 78. VIVUS (Qsymia) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 79. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 80. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. VIVUS (Qsymia) Main Business
Table 82. VIVUS (Qsymia) Latest Developments
Table 83. Novo Nordisk A/S Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 84. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolios and Specifications
Table 85. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novo Nordisk A/S Main Business
Table 87. Novo Nordisk A/S Latest Developments
Table 88. Rhythm Pharmaceuticals (Imcivree) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 89. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 90. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Rhythm Pharmaceuticals (Imcivree) Main Business
Table 92. Rhythm Pharmaceuticals (Imcivree) Latest Developments
Table 93. Eli Lilly and Company (TRICARE) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 95. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Eli Lilly and Company (TRICARE) Main Business
Table 97. Eli Lilly and Company (TRICARE) Latest Developments
Table 98. CHEPLAPHARM (Xenical) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 99. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 100. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. CHEPLAPHARM (Xenical) Main Business
Table 102. CHEPLAPHARM (Xenical) Latest Developments
Table 103. Pfizer Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Prescription Weight Loss Pills Product Portfolios and Specifications
Table 105. Pfizer Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Teva Pharmaceutical (Actavis) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 110. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Teva Pharmaceutical (Actavis) Main Business
Table 112. Teva Pharmaceutical (Actavis) Latest Developments
Table 113. Haleon Group (alli) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 114. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 115. Haleon Group (alli) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Haleon Group (alli) Main Business
Table 117. Haleon Group (alli) Latest Developments
Table 118. Sanofi (Adlyxin) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 120. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Sanofi (Adlyxin) Main Business
Table 122. Sanofi (Adlyxin) Latest Developments
Table 123. AstraZeneca (BYDUREON BCise) Basic Information, Prescription Weight Loss Pills Manufacturing Base, Sales Area and Its Competitors
Table 124. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolios and Specifications
Table 125. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. AstraZeneca (BYDUREON BCise) Main Business
Table 127. AstraZeneca (BYDUREON BCise) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Prescription Weight Loss Pills
Figure 2. Prescription Weight Loss Pills Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Weight Loss Pills Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Prescription Weight Loss Pills Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Prescription Weight Loss Pills Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Prescription Weight Loss Pills Sales Market Share by Country/Region (2025)
Figure 10. Prescription Weight Loss Pills Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of OralTablets
Figure 12. Product Picture of Oral Capsules
Figure 13. Product Picture of Injections
Figure 14. Global Prescription Weight Loss Pills Sales Market Share by Type in 2026
Figure 15. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026)
Figure 16. Prescription Weight Loss Pills Consumed in Hospital
Figure 17. Global Prescription Weight Loss Pills Market: Hospital (2021-2026) & (K Units)
Figure 18. Prescription Weight Loss Pills Consumed in Pharmacy
Figure 19. Global Prescription Weight Loss Pills Market: Pharmacy (2021-2026) & (K Units)
Figure 20. Global Prescription Weight Loss Pills Sale Market Share by Application (2025)
Figure 21. Global Prescription Weight Loss Pills Revenue Market Share by Application in 2026
Figure 22. Prescription Weight Loss Pills Sales by Company in 2026 (K Units)
Figure 23. Global Prescription Weight Loss Pills Sales Market Share by Company in 2026
Figure 24. Prescription Weight Loss Pills Revenue by Company in 2026 ($ millions)
Figure 25. Global Prescription Weight Loss Pills Revenue Market Share by Company in 2026
Figure 26. Global Prescription Weight Loss Pills Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Prescription Weight Loss Pills Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 29. Americas Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 30. APAC Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 31. APAC Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 32. Europe Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 33. Europe Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 36. Americas Prescription Weight Loss Pills Sales Market Share by Country in 2026
Figure 37. Americas Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Figure 38. Americas Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 39. Americas Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 40. United States Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Prescription Weight Loss Pills Sales Market Share by Region in 2026
Figure 45. APAC Prescription Weight Loss Pills Revenue Market Share by Region (2021-2026)
Figure 46. APAC Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 47. APAC Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 48. China Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 52. India Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Prescription Weight Loss Pills Sales Market Share by Country in 2026
Figure 56. Europe Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Figure 57. Europe Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 58. Europe Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 59. Germany Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 60. France Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 67. Egypt Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills in 2026
Figure 73. Manufacturing Process Analysis of Prescription Weight Loss Pills
Figure 74. Industry Chain Structure of Prescription Weight Loss Pills
Figure 75. Channels of Distribution
Figure 76. Global Prescription Weight Loss Pills Sales Market Forecast by Region (2027-2032)
Figure 77. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Prescription Weight Loss Pills Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Prescription Weight Loss Pills Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Prescription Weight Loss Pills
Figure 2. Prescription Weight Loss Pills Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Weight Loss Pills Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Prescription Weight Loss Pills Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Prescription Weight Loss Pills Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Prescription Weight Loss Pills Sales Market Share by Country/Region (2025)
Figure 10. Prescription Weight Loss Pills Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of OralTablets
Figure 12. Product Picture of Oral Capsules
Figure 13. Product Picture of Injections
Figure 14. Global Prescription Weight Loss Pills Sales Market Share by Type in 2026
Figure 15. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026)
Figure 16. Prescription Weight Loss Pills Consumed in Hospital
Figure 17. Global Prescription Weight Loss Pills Market: Hospital (2021-2026) & (K Units)
Figure 18. Prescription Weight Loss Pills Consumed in Pharmacy
Figure 19. Global Prescription Weight Loss Pills Market: Pharmacy (2021-2026) & (K Units)
Figure 20. Global Prescription Weight Loss Pills Sale Market Share by Application (2025)
Figure 21. Global Prescription Weight Loss Pills Revenue Market Share by Application in 2026
Figure 22. Prescription Weight Loss Pills Sales by Company in 2026 (K Units)
Figure 23. Global Prescription Weight Loss Pills Sales Market Share by Company in 2026
Figure 24. Prescription Weight Loss Pills Revenue by Company in 2026 ($ millions)
Figure 25. Global Prescription Weight Loss Pills Revenue Market Share by Company in 2026
Figure 26. Global Prescription Weight Loss Pills Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Prescription Weight Loss Pills Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 29. Americas Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 30. APAC Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 31. APAC Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 32. Europe Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 33. Europe Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Prescription Weight Loss Pills Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Prescription Weight Loss Pills Revenue 2021-2026 ($ millions)
Figure 36. Americas Prescription Weight Loss Pills Sales Market Share by Country in 2026
Figure 37. Americas Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Figure 38. Americas Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 39. Americas Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 40. United States Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Prescription Weight Loss Pills Sales Market Share by Region in 2026
Figure 45. APAC Prescription Weight Loss Pills Revenue Market Share by Region (2021-2026)
Figure 46. APAC Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 47. APAC Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 48. China Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 52. India Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Prescription Weight Loss Pills Sales Market Share by Country in 2026
Figure 56. Europe Prescription Weight Loss Pills Revenue Market Share by Country (2021-2026)
Figure 57. Europe Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 58. Europe Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 59. Germany Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 60. France Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Prescription Weight Loss Pills Sales Market Share by Application (2021-2026)
Figure 67. Egypt Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Prescription Weight Loss Pills Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills in 2026
Figure 73. Manufacturing Process Analysis of Prescription Weight Loss Pills
Figure 74. Industry Chain Structure of Prescription Weight Loss Pills
Figure 75. Channels of Distribution
Figure 76. Global Prescription Weight Loss Pills Sales Market Forecast by Region (2027-2032)
Figure 77. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Prescription Weight Loss Pills Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Prescription Weight Loss Pills Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Prescription Weight Loss Pills Revenue Market Share Forecast by Application (2027-2032)
